COVID-19 (Coronavirus) Update: Testing and Information | Vaccine Updates | Visitor Guidelines

PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS SAmples Study

Protocol No
IIT-TSAI-PANCREAS-TRIAL
Principal Investigator
Susan Tsai
Phase
II
Summary
This project is being done to find out if your tumor has specific molecular characteristics to be eligible for the study. If you participate in the study, this analysis will also help determine your treatment.
Description
PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples (PANCREAS)
Participating Institutions
Froedtert Hospital
Honor Health
Status
OPEN TO ACCRUAL